STOCK TITAN

[8-K] Nukkleus Inc. Reports Material Event

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Nukkleus Inc. (NUKK) furnished a Regulation FD update announcing a press release about the proposed initial public offering of units of SC II Acquisition Corp. I, a newly formed special purpose acquisition company and indirect subsidiary of Nukkleus.

The notice states that a preliminary, subject-to-completion prospectus has been filed with the SEC and is not yet effective, and that no offers or sales of these securities may occur prior to effectiveness. The information under Item 7.01, including the press release attached as Exhibit 99.1, is furnished and not deemed filed under the Exchange Act.

Nukkleus Inc. (NUKK) ha fornito un aggiornamento Regulation FD annunciando un comunicato stampa riguardante l'offerta pubblica iniziale proposta di unità di SC II Acquisition Corp. I, una nuova SPAC e controllata indiretta di Nukkleus.

L'avviso afferma che è stato depositato con la SEC un prospetto preliminare, soggetto a completamento e non ancora efficace, e che nessuna offerta o vendita di tali titoli può avvenire prima dell'efficacia. Le informazioni relative all'Item 7.01, incluso il comunicato stampa allegato come Exhibit 99.1, sono fornite a titolo informativo e non si considerano presentate ai sensi della Exchange Act.

Nukkleus Inc. (NUKK) proporcionó una actualización Regulation FD anunciando un comunicado de prensa sobre la oferta pública inicial propuesta de unidades de SC II Acquisition Corp. I, una nueva empresa de propósito especial y subsidiaria indirecta de Nukkleus.

El aviso indica que se ha presentado ante la SEC un prospecto preliminar, sujeto a finalización y que aún no es efectivo, y que no se pueden realizar ofertas o ventas de estos valores antes de su efectividad. La información bajo el ítem 7.01, incluido el comunicado de prensa adjunto como Exhibit 99.1, se facilita y no se considera presentada conforme a la Exchange Act.

Nukkleus Inc. (NUKK) 은 Regulation FD 업데이트를 제공하여 SC II Acquisition Corp. I의 제안된 초기 공개 모집(IPO)에 관한 보도자료를 발표했다고 공지했습니다. 이는 Nukkleus의 신규 설립된 특별목적인수법인(SPAC) 및 간접 자회사입니다.

고지에 따르면 SEC에 예비적으로 제출된 완성 전제 prospectus가 있으며 아직 효과가 없고, 효력발생 이전에는 이러한 증권에 대한 제안이나 매매가 불가합니다. 항목 7.01에 대한 정보(Exhibit 99.1로 첨부된 보도자료 포함)는 제출되었으며, Exchange Act에 따라 제출된 것으로 간주되지 않습니다.

Nukkleus Inc. (NUKK) a fourni une mise à jour Regulation FD annonçant un communiqué de presse concernant l'offre publique initiale proposée d'unités de SC II Acquisition Corp. I, une nouvelle société d'acquisition à vocation spécifique et filiale indirecte de Nukkleus.

L'avis indique qu'un prospectus préliminaire, sous réserve d'achèvement, a été déposé auprès de la SEC et n'est pas encore efficace, et qu'aucune offre ou vente de ces valeurs ne peut avoir lieu avant l'efficacité. Les informations relatives à l'Item 7.01, y compris le communiqué de presse joint en tant qu'Exhibit 99.1, sont fournies et ne sont pas considérées comme déposées en vertu de la Exchange Act.

Nukkleus Inc. (NUKK) hat ein Regulation FD-Update vorgelegt, das eine Pressemitteilung über die vorgesehene Erstversion von Anteilen von SC II Acquisition Corp. I ankündigt, eine neu gegründete Special Purpose Acquisition Company und indirekte Tochtergesellschaft von Nukkleus.

Die Mitteilung besagt, dass ein vorläufiges, bedingt wirksames Prospekt bei der SEC eingereicht wurde und noch nicht wirksam ist, und dass vor dem Inkrafttreten keine Angebote oder Verkäufe dieser Wertpapiere erfolgen dürfen. Die Informationen unter Item 7.01, einschließlich der beigefügten Pressemitteilung als Exhibit 99.1, werden vorgelegt und gelten nicht als gemäß dem Exchange Act eingereicht.

Nukkleus Inc. (NUKK) قد قدّمت تحديث Regulation FD معلنة عن بيان صحفي بخصوص العرض العام الأول المقترح للوحدات من SC II Acquisition Corp. I، وهي شركة استحواذ ذات هدف خاص جديدة وفرع غير مباشر لنكلّس.

تنص الإشعار على أن prospectus أوليًا، رهين الإكمال، قد تم تقديمه إلى هيئة الأوراق المالية SEC وهو غير ساري المفعول حتى الآن، وأنه لا يجوز أي عروض أو مبيعات لهذه الأوراق قبل سريانها. المعلومات الواردة في البند 7.01، بما في ذلك البيان الصحفي المرفق كمعروض 99.1، مقدمة وليست مقدمة وفقًا لـ Exchange Act.

Nukkleus Inc. (NUKK) 已提供一份 Regulation FD 更新,宣布关于 SC II Acquisition Corp. I 提议的初始公开发行单位的新闻稿,该公司是一个新成立的特殊目的收购公司并且是 Nukkleus 的间接子公司。

通知称,已向 SEC 提交了一个为完成而设的初步招股说明书,尚未生效,且在生效前不得进行任何此等证券的要约或销售。第 7.01 项下的信息,包括作为附件 Exhibit 99.1 的新闻稿,被提供,但不被视为根据《交易法》提交。

Positive
  • None.
Negative
  • None.

Insights

Furnished 8-K discloses a proposed SPAC IPO by an indirect subsidiary; plans are preliminary and uncertain, with no terms or timing finalized.

Nukkleus Inc. furnished notice of a press release about the proposed initial public offering of units of SC II Acquisition Corp. I, a newly formed SPAC and indirect subsidiary. A registration statement with a preliminary prospectus has been filed but is not effective, and no offers or sales can occur until effectiveness. In simple terms, a SPAC raises cash in an IPO to later merge with a private company.

The disclosure is informational under Item 7.01 (Reg FD) and is explicitly furnished, not filed, which limits Exchange Act liability and signals preliminary status. The company provides no offering size, pricing, use of proceeds, or timeline. The forward-looking caution emphasizes that completion depends on market, legal, and regulatory conditions, and may not occur at all.

What matters: if the IPO proceeds, the subsidiary could hold a cash pool to pursue a future business combination, which could create optionality for the broader organization. Concrete items to watch next include SEC effectiveness of the registration statement, any disclosed unit structure and size, and sponsor/management details once available. The earliest reference point is October 17, 2025; subsequent filings and an effective registration would indicate progress.

Nukkleus Inc. (NUKK) ha fornito un aggiornamento Regulation FD annunciando un comunicato stampa riguardante l'offerta pubblica iniziale proposta di unità di SC II Acquisition Corp. I, una nuova SPAC e controllata indiretta di Nukkleus.

L'avviso afferma che è stato depositato con la SEC un prospetto preliminare, soggetto a completamento e non ancora efficace, e che nessuna offerta o vendita di tali titoli può avvenire prima dell'efficacia. Le informazioni relative all'Item 7.01, incluso il comunicato stampa allegato come Exhibit 99.1, sono fornite a titolo informativo e non si considerano presentate ai sensi della Exchange Act.

Nukkleus Inc. (NUKK) proporcionó una actualización Regulation FD anunciando un comunicado de prensa sobre la oferta pública inicial propuesta de unidades de SC II Acquisition Corp. I, una nueva empresa de propósito especial y subsidiaria indirecta de Nukkleus.

El aviso indica que se ha presentado ante la SEC un prospecto preliminar, sujeto a finalización y que aún no es efectivo, y que no se pueden realizar ofertas o ventas de estos valores antes de su efectividad. La información bajo el ítem 7.01, incluido el comunicado de prensa adjunto como Exhibit 99.1, se facilita y no se considera presentada conforme a la Exchange Act.

Nukkleus Inc. (NUKK) 은 Regulation FD 업데이트를 제공하여 SC II Acquisition Corp. I의 제안된 초기 공개 모집(IPO)에 관한 보도자료를 발표했다고 공지했습니다. 이는 Nukkleus의 신규 설립된 특별목적인수법인(SPAC) 및 간접 자회사입니다.

고지에 따르면 SEC에 예비적으로 제출된 완성 전제 prospectus가 있으며 아직 효과가 없고, 효력발생 이전에는 이러한 증권에 대한 제안이나 매매가 불가합니다. 항목 7.01에 대한 정보(Exhibit 99.1로 첨부된 보도자료 포함)는 제출되었으며, Exchange Act에 따라 제출된 것으로 간주되지 않습니다.

Nukkleus Inc. (NUKK) a fourni une mise à jour Regulation FD annonçant un communiqué de presse concernant l'offre publique initiale proposée d'unités de SC II Acquisition Corp. I, une nouvelle société d'acquisition à vocation spécifique et filiale indirecte de Nukkleus.

L'avis indique qu'un prospectus préliminaire, sous réserve d'achèvement, a été déposé auprès de la SEC et n'est pas encore efficace, et qu'aucune offre ou vente de ces valeurs ne peut avoir lieu avant l'efficacité. Les informations relatives à l'Item 7.01, y compris le communiqué de presse joint en tant qu'Exhibit 99.1, sont fournies et ne sont pas considérées comme déposées en vertu de la Exchange Act.

Nukkleus Inc. (NUKK) hat ein Regulation FD-Update vorgelegt, das eine Pressemitteilung über die vorgesehene Erstversion von Anteilen von SC II Acquisition Corp. I ankündigt, eine neu gegründete Special Purpose Acquisition Company und indirekte Tochtergesellschaft von Nukkleus.

Die Mitteilung besagt, dass ein vorläufiges, bedingt wirksames Prospekt bei der SEC eingereicht wurde und noch nicht wirksam ist, und dass vor dem Inkrafttreten keine Angebote oder Verkäufe dieser Wertpapiere erfolgen dürfen. Die Informationen unter Item 7.01, einschließlich der beigefügten Pressemitteilung als Exhibit 99.1, werden vorgelegt und gelten nicht als gemäß dem Exchange Act eingereicht.

false 0001787518 0001787518 2025-10-17 2025-10-17 0001787518 NUKK:CommonStock0.0001ParValuePerShareMember 2025-10-17 2025-10-17 0001787518 NUKK:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor92.00PerShareMember 2025-10-17 2025-10-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 17, 2025

 

NUKKLEUS INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-39341   38-3912845
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (IRS Employer
Identification Number)

 

575 Fifth Avenue, 14th Floor

New York, New York 10017

(Address of principal executive offices)

 

646-257-4214

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   NUKK   The Nasdaq Stock Market LLC
         
Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share   NUKKW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On October 17, 2025, Nukkleus, Inc., (the “Company”) issued a press release regarding the proposed initial public offering of units of SC II Acquisition Corp. I (the “SCII”), a newly formed special purpose acquisition company and indirect subsidiary of the Company. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

A registration statement, including a prospectus, which is preliminary and subject to completion, relating to the proposed offering has been filed with the Securities and Exchange Commission (the “SEC”) but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sales of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. When available, copies of the preliminary prospectus relating to the offering may be obtained from D. Boral Capital LLC: Attn: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at info@dboralcapital.com, or by telephone at (212) 970-5150, or from the SEC’s website at www.sec.gov.

 

The information furnished under this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.   Description
99.1   Press Release of Nukkleus, Inc. dated October 17, 2025.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated size, timing, structure, and success of the proposed IPO of SC II, the expected composition of its sponsor and management team, and the prospects of completing a future business combination. There can be no assurance that the proposed offering of SC II will be completed on the terms described herein, within the expected timeframe, or at all. The completion of the proposed offering and the subsequent business-combination process remain subject to market, legal, and regulatory conditions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NUKKLEUS INC.
     
Date: October 17, 2025 By: /s/ Menachem Shalom
  Name:  Menachem Shalom
  Title: Chief Executive Officer

 

2

 

FAQ

What did NUKK announce in its 8-K on October 17, 2025?

Nukkleus disclosed a press release about the proposed IPO of units of SC II Acquisition Corp. I, its indirect SPAC subsidiary.

What stage is the SC II Acquisition Corp. I IPO?

A registration statement with a preliminary, subject-to-completion prospectus has been filed with the SEC but is not yet effective.

Can SC II’s securities be sold before SEC effectiveness?

No. The filing states securities may not be sold, nor may offers be accepted, prior to the registration statement becoming effective.

Where can investors access the preliminary prospectus for SC II?

When available, from D. Boral Capital LLC (590 Madison Ave, 39th Floor, New York, NY 10022; info@dboralcapital.com; (212) 970-5150) or at www.sec.gov.

How is the 8-K information treated under the Exchange Act?

Information under Item 7.01, including Exhibit 99.1, is furnished and not deemed filed or subject to Section 18 liabilities.

What securities of NUKK are listed on Nasdaq?

Common Stock (NUKK) and Warrants (NUKKW), with each warrant exercisable for one share of common stock for $92.00 per share.
Nukkleus Inc.

NASDAQ:NUKK

NUKK Rankings

NUKK Latest News

NUKK Latest SEC Filings

NUKK Stock Data

93.50M
5.33M
28.2%
2.99%
11.31%
Software - Application
Services-management Consulting Services
Link
United States
NEW YORK